Verrica Pharmaceuticals (VRCA)

• Market cap: $35.5M
• 1 day: -2.34%
• 5 days: -5.76%
• 1 month: -12.56%
• 3 months: -44.62%
• 6 months: -18.97%
• Year to date: -46.51%
• 1 year: -75.9%
• 5 years: -95.17%
• 10 years: -97.85%
• Sector: Healthcare
• Industry: Biotechnology

About: Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Employees: 71